MDT - Medtronic plc

NYSE - NYSE Delayed Price. Currency in USD
-0.71 (-0.64%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close110.38
Bid109.16 x 800
Ask109.76 x 800
Day's Range109.30 - 110.48
52 Week Range81.66 - 111.24
Avg. Volume4,500,512
Market Cap147.141B
Beta (3Y Monthly)0.49
PE Ratio (TTM)33.63
EPS (TTM)3.26
Earnings DateNov 19, 2019
Forward Dividend & Yield2.16 (1.96%)
Ex-Dividend Date2019-09-26
1y Target Est117.00
Trade prices are not sourced from all markets
  • GlobeNewswire

    Medtronic Named a Leading Sustainability Company

    Medtronic plc (MDT) today announced that it has been recognized as one of the world's leading companies for sustainability with its inclusion in the Dow Jones Sustainability North America Index (DJSI North America) for the twelfth consecutive year. The DJSI North America includes a select group of companies based on their performance across a variety of sustainability criteria, including economic performance, environmental stewardship, social responsibility, and corporate governance. This adds to the recognition Medtronic received earlier this year through its continued inclusion in the FTSE4Good Index Series.

  • Medtronic (MDT) Soars to 52-Week High, Time to Cash Out?

    Medtronic (MDT) Soars to 52-Week High, Time to Cash Out?

    Medtronic (MDT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • Is Medtronic (MDT) Outperforming Other Medical Stocks This Year?

    Is Medtronic (MDT) Outperforming Other Medical Stocks This Year?

    Is (MDT) Outperforming Other Medical Stocks This Year?

  • IoMT Becomes the Buzzword in New Age MedTech Investing

    IoMT Becomes the Buzzword in New Age MedTech Investing

    Increasing adoption of cloud platforms, phones, phablets, tablets and other smart devices as well as apps is making acceptance of IoMT easier among the masses.

  • 3D Printing Gaining Popularity: 3 MedTech Stocks to Watch

    3D Printing Gaining Popularity: 3 MedTech Stocks to Watch

    In the near future, there is a probability of 3D-printed implantable organs becoming a reality, thereby increasing the number of lives saved.


    Medtronic Plc (MDT) EVP & Group President Diabetes Hooman Hakami Sold $8.9 million of Shares

    EVP & Group President Diabetes of Medtronic Plc (30-Year Financial, Insider Trades) Hooman Hakami (insider trades) sold 82,877 shares of MDT on 09/10/2019 at an average price of $107.31 a share. Continue reading...

  • Here’s who America’s CEOs are backing in the Democratic presidential race

    Here’s who America’s CEOs are backing in the Democratic presidential race

    Nineteen chief executive officers of S&P 500 companies so far have given their own money to 2020 Democratic White House hopefuls.

  • United Therapeutics' Trevyent NDA for PAH Accepted by FDA

    United Therapeutics' Trevyent NDA for PAH Accepted by FDA

    United Therapeutics (UTHR) announces acceptance of Trevyent NDA by the FDA for pulmonary arterial hypertension.

  • 5 High-Flying Stocks Near 52-Week High That Can Scale Higher

    5 High-Flying Stocks Near 52-Week High That Can Scale Higher

    Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.

  • Bruker (BRKR) Introduces the nanoIR3-s Broadband System

    Bruker (BRKR) Introduces the nanoIR3-s Broadband System

    The launch of the FTIR spectroscopy system complements Bruker's (BRKR) target to boost its portfolio of nanoIR products.

  • ETFs to Gain as Surgical Robots Rise in Popularity

    ETFs to Gain as Surgical Robots Rise in Popularity

    We highlight ETFs which are set to gain from an expanding surgical robotic market on factors like growing demand for automation in healthcare, rising cases of chronic diseases and ageing population.

  • GNC Holdings Rides on New Pacts Amid Weak Same Store Sales

    GNC Holdings Rides on New Pacts Amid Weak Same Store Sales

    GNC Holdings' (GNC) recent joint venture with vitamins and nutritional supplement manufacturer International Vitamin Corporation shows high prospects at present.

  • Medtronic's (MDT) MiniMed 670G Gains German Reimbursement

    Medtronic's (MDT) MiniMed 670G Gains German Reimbursement

    Medtronic's (MDT) MiniMed 670G is witnessing a solid uptake in the United States ever since its launch last year.

  • Medtronic's (MDT) IN.PACT AV Access Study Results Bode Well

    Medtronic's (MDT) IN.PACT AV Access Study Results Bode Well

    The results of the study will prove to be a major stride for Medtronic (MDT) to treat patient suffering from renal diseases.

  • Illumina Banks on New Product Suite Despite Margin Woes

    Illumina Banks on New Product Suite Despite Margin Woes

    The unveiling of Veriseq NIPT v2 and Illumina's (ILMN) alliance with AnchorDx in the second quarter further raise investor confidence in the stock.

  • Abbott (ABT) Launches Pivotal Trial TRILUMINATE in the US

    Abbott (ABT) Launches Pivotal Trial TRILUMINATE in the US

    Given the lack of an alternative therapy to replace tricuspid regurgitation surgery, Abbott (ABT) should be at an advantage in this space.

  • Top Ranked Growth Stocks to Buy for September 9th

    Top Ranked Growth Stocks to Buy for September 9th

    Top Ranked Growth Stocks to Buy for September 9th

  • Edwards Lifesciences Hits a 52-Week High on Solid Prospects

    Edwards Lifesciences Hits a 52-Week High on Solid Prospects

    Edwards Lifesciences (EW) gains from recent impressive developments.

  • GlobeNewswire

    Medtronic Announces Reimbursement in Germany for MiniMed™ 670G Insulin Pump System for Individuals with Type 1 Diabetes

    Medtronic plc (MDT), the global leader in medical technology, services and solutions, today announced it has secured reimbursement for the MiniMed™ 670G insulin pump system with the German Federal Association of the Statutory Health Insurances (GKV-SV). The MiniMed 670G system is the only commercially available technology in the world that personalizes the delivery of basal insulin 24 hours a day based on real-time insulin needs, to maximize Time in Range for an individual living with type 1 diabetes. “We have already seen the difference the MiniMed 670G system has had for tens of thousands of people living with type 1 diabetes across the world who are now experiencing better clinical and quality of life outcomes,” said Dr. Robert Vigersky, chief medical officer, Global Medical and Clinical Affairs for the Diabetes Group at Medtronic.

  • Here's Why You Should Invest in Amedisys (AMED) Right Now

    Here's Why You Should Invest in Amedisys (AMED) Right Now

    Amedisys (AMED) is currently enjoying investors' confidence, thanks to solid prospects.

  • GlobeNewswire

    IN.PACT AV Access Trial Meets Primary Safety and Effectiveness Endpoints

    DUBLIN and BARCELONA, Spain, Sept. 07, 2019 -- Medtronic plc (NYSE:MDT) announced the first-ever results from the IN.PACT AV Access clinical study comparing the investigational.

  • 10 Buy-and-Hold Stocks to Own Forever

    10 Buy-and-Hold Stocks to Own Forever

    [Editor's note: This story was previously published in August 2019. It has since been updated and republished.]Investing to "buy and hold" is trickier than it looks. The increasing pace of technological change means even the most successful, dominant companies have to continually adapt to keep up. Industries like energy, real estate and even consumer products are facing potentially significant long-term changes going forward.In any era, amassing a collection of retirement stocks simply by buying the best companies and holding them for years can be a risky endeavor.InvestorPlace - Stock Market News, Stock Advice & Trading TipsGeneral Motors (NYSE:GM) was a classic "widows and orphans" stock until the last decade when GM wound up going bankrupt. GM shares basically haven't moved in a quarter of a century. United States Steel (NYSE:X) once was a pillar of corporate America and a buy-and-hold stock. Polaroid and Eastman Kodak were once blue-chip stocks. Both went bankrupt as cameras changed from film to digital. * 7 Stocks to Buy In a Flat Market But there still are stocks to buy and hold out there that can last forever, while offering dividend income along the way.Here are ten such retirement stocks to buy and hold forever. Bank of America (BAC)Source: Tero Vesalainen / Dividend Yield: 2.56%It might seem strange to open the list with Bank of America (NYSE:BAC). After all, we're only a bit more than a decade on from the financial crisis.During that crisis, BofA acquisition Countrywide Financial blew up in spectacular fashion, after pioneering many of the risky tactics that led to the bubble and subsequent bust.But this is a different BofA.Net consumer charge-offs hit a decade-long low last year. Its performance on credit metrics is strong. Government regulations have been criticized as slowing growth -- but they've undoubtedly lowered risk as well, even if observers might argue that a better balance is needed. * 7 "Boring" Stocks With Exciting Prospects No less than Warren Buffett is now BofA's largest shareholder, through his Berkshire Hathaway Inc. (NYSE:BRK.A, NYSE:BRK.B). And the Oracle of Omaha is fond of saying that his favorite holding period is "forever."That seems likely true for BAC stock as well. Diageo (DEO)Dividend Yield: 2.07%Change has come to the alcohol industry, with the number of breweries exploding worldwide and new distilleries popping up as well. The brands owned by Diageo (NYSE:DEO) are well-positioned to adapt to shifting tastes.Diageo owns classic brands like Johnnie Walker whiskey, Tanqueray gin, Smirnoff vodka, and Harp and Guinness beer, among many others. What most have in common is a timeless quality and worldwide brand recognition.As a result, while beverage giants like Coca-Cola (NYSE:KO) and Anheuser Busch InBev (NYSE:BUD) have struggled with earnings growth, Diageo grew net income by 13.5% in fiscal 2018 and expects consistent growth going forward.Yet with a trailing multiple of 26.5, and with a dividend yield of 2%, Diageo stock isn't all that dearly valued. Long-term investors would do well to own DEO and perhaps use the dividends to buy a bottle or two of fine whisky. Medtronic (MDT)Source: JHVEPhoto / Dividend Yield: 2.11%In this day and age, the U.S. healthcare market, in particular, seems potentially volatile. Concerns about increased spending and political battles over the Affordable Care Act create more questions than answers.But even with that uncertainty, Medtronic (NYSE:MDT) isn't going anywhere. The company's devices are an integral part of modern medicine, ranging from pacemakers to stents to bone grafts to imaging systems.Even the risks involved in the sector look priced into MDT. Medtronic's days of double-digit annual growth may well be behind it, but it's not finished increasing earnings or dividends. MDT stock likely isn't finished rising, either. * 7 A-Rated Stocks to Buy Under $10 NextEra Energy (NEE)Source: Shutterstock Dividend Yield: 2.27%Utility stocks are among the most common safe, buy-and-hold stocks. NextEra Energy (NYSE:NEE) is now the largest electric utility in the U.S. by market capitalization. That might actually be the only problem with NEE stock.NextEra shares gained 24% year-to-date, and trades just off record highs. Potential valuation concerns aside, NextEra looks like a winner. It serves customers in the southern Florida region, still one of the nation's fastest-growing areas.A 22.6 forward P/E multiple is high for the space but not outlandishly so. And a 2.37% dividend yield provides income along the way.Investors looking for value in the space might look for a smaller play like cheaper Dominion Energy (NYSE:D). But it's usually worth paying for quality, and NextEra Energy looks like one of the best utility stocks out there. McCormick & Company (MKC)Source: Shutterstock Dividend Yield: 1.39%McCormick & Company (NYSE:MKC) is another quality company whose valuation might spook some investors. But MKC stock very rarely is offered cheaply.The company's market leadership in spices and seasonings provides both an impressive moat and protection against economic downturns. MKC stock did dip after the company acquired French's mustard and Frank's RedHot sauce from Reckitt Benckiser (OTCMKTS:RBGLY) at a price that looked a bit high to many investors. But MKC has recovered those gains and then some.Top-line growth for McCormick likely isn't going to be explosive, but it will be steady. The same has been true of MKC stock, which has returned an average of 13% a year over the past decade, including dividends. * 10 Companies Using AI to Grow With continuous cost-cutting initiatives, the contribution from the acquired brands and organic growth (and growth in organic products), MKC still should be able to provide double-digit annual returns going forward as well. Allstate (ALL)Source: Shutterstock Dividend Yield: 1.92%Allstate Corp (NYSE:ALL) long has used the tagline, "You're in good hands," and it's true for Allstate investors as well.ALL stock has almost quadrupled from late-2011 lows. And there could be more upside to come. After all, Allstate isn't particularly expensive, trading at a 14 P/E.Once any short-term worries subside, ALL should resume its march upward. International Flavors & Fragrances (IFF)Source: Shutterstock Dividend Yield: 2.62%International Flavors & Fragrances (NYSE:IFF) is a company most consumers encounter every day without knowing it and many investors aren't exactly hip to it, either.As its name suggests, the company develops flavors & fragrances across 13 categories, including cosmetics, perfumes, beverages and sweet flavors. Sales and earnings have increased consistently and so has IFF's share price. At a 53 P/E, IFF does look a bit pricey. But, as with McCormick and other stocks on this list, investors should pay for quality. * 7 Tech Industry Dividend Stocks for Growth and Income IFF's hidden, but key role, in so many industries, gives it a great deal of protection against both competition and macro factors. Acquisitions and a growing cosmetic additive business both provide room for growth.Consumers may not know IFF, but investors should. Lamb Weston (LW)Source: Shutterstock Dividend Yield: 1.11%Lamb Weston (NYSE:LW) was spun off from Conagra Brands (NYSE:CAG) last year. Lamb Weston is the No. 1 potato producer in the United States. In fact, it manufactures the well-known fries at McDonald's (NYSE:MCD), among other restaurant chains.Lamb Weston also has a consumer business (including a small segment that manufactures frozen vegetables), while serving restaurants of all sizes. Health concerns might seem a long-term headwind against the business, but growth has been steady for years, and margins continue to improve.LW is targeting international markets for growth, as French fries have much more limited penetration, while international audiences generally are intrigued by Americanized products.Despite growth and leading market share, LW stock isn't particularly cheap, trading at about 19 times next year's earnings. The company did pick up a fair amount of debt in the CAG spinoff. But it's paying that debt down, which should lower interest expense and boost cash flow going forward.With many similar stocks trading at much higher multiples, LW seems to have room for upside. And international growth should offset any health-related concerns in the U.S., should they arise. America's love affair with French fries isn't going to suddenly end, and that should ensure years of stability for Lamb Weston at least. Fortune Brands (FBHS)Source: Shutterstock Dividend Yield: 1.71%Investors are commonly advised to diversify their portfolio. Fortune Brands Home & Security (NYSE:FBHS) has done just that.The company operates in four segments: Cabinets, Plumbing, Doors, and Security. Among its well-known brands are Moen in plumbing, and MasterLock in security.FBHS is more of a cyclical stock than most on this list, and the company no doubt has benefited from the steady if slow, housing recovery in the U.S.But the company's products also generate relatively stable replacement demand, and a 1.6% dividend yield provides modest, but growing, income. * 7 Deeply Discounted Energy Stocks to Buy Fortune Brands has been an impressive company since its founding and a solid stock since its 2011 IPO. There may be a bit more volatility here, but that's a worthwhile price to pay for long-term investors. There's enough value in Fortune Brands to ride out any market jitters. Republic Services (RSG)Source: Shutterstock Dividend Yield: 1.82%Republic Services (NYSE:RSG) is a bit smaller and likely a lot less well-known than rival Waste Management (NYSE:WM). But in this case, that's not necessarily a bad thing.Republic Services has outgrown its larger competitor in both sales and earnings over the past five years. RSG stock has modestly outperformed WM over the same period as well. Investors appear to believe that will continue, as Republic Services is valued a bit higher than Waste Management, at least based on forward earnings multiples.Both RSG and WM are solid long-term plays. Contracted revenue and steady demand should support both companies for years to come. There's room for further acquisitions in a relatively fragmented space. Republic Services gets the nod here due to slightly better growth and more room for margin improvement.But investors looking for safe, stable growth can't go wrong with either RSG or WM.As of this writing, Vince Martin was long MKC. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Value Stocks to Buy for the Second Half * 7 Hot Stocks to Buy for a Seemingly Sleepy Summer * 6 Chip Stocks Staring At Big Headwinds in 2019 The post 10 Buy-and-Hold Stocks to Own Forever appeared first on InvestorPlace.

  • Top 6 Holdings of Jeremy Grantham's GMO

    Top 6 Holdings of Jeremy Grantham's GMO

    Firm’s largest holdings include Microsoft and Berkshire position Apple Continue reading...

  • Stryker's Mobius Imaging Buyout to Boost Its Spine Division

    Stryker's Mobius Imaging Buyout to Boost Its Spine Division

    Stryker (SYK) expects the buyout to remain neutral to its 2019 earnings.

  • Is Medtronic About to Give Intuitive Surgical a Run for Its Money?
    Motley Fool

    Is Medtronic About to Give Intuitive Surgical a Run for Its Money?

    There's a new surgical robot coming soon. Is the market big enough for da Vinci and a big competitor's rival system?